Terry Rosen is the CEO of Arcus Biosciences, a biotechnology company he co-founded in 2015. With over 30 years of experience in drug discovery and development, Rosen has held significant roles at Flexus Biosciences, Amgen, and Tularik. His leadership at Arcus is marked by a focus on innovative cancer treatments that harness the power of the immune system.
Who is the CEO of Arcus Biosciences?
With a career spanning over three decades in the biotechnology and pharmaceutical industries, Terry Rosen has established himself as a prominent figure in drug discovery and development. Before co-founding Arcus Biosciences in 2015, where he currently serves as CEO, Rosen was the CEO of Flexus Biosciences. His extensive experience includes executive roles at Amgen and Tularik, as well as scientific and management positions at Pfizer and Abbott Laboratories.
His leadership at Arcus Biosciences is characterized by a commitment to pioneering cancer treatments that leverage the immune system to combat the disease.
Work History
Throughout his illustrious career, Terry Rosen has held various significant positions in the biotechnology and pharmaceutical industries. Here is a list of the places he has worked previously:
- Arcus Biosciences - CEO (2015 - Present)
- Flexus Biosciences - CEO (2013 - 2015)
- Amgen - Executive Roles (2004 - 2013)
- Tularik - Executive Roles (2000 - 2004)
- Pfizer - Scientific and Management Positions (1995 - 2000)
- Abbott Laboratories - Scientific and Management Positions (1985 - 1995)
Education History
Terry Rosen's educational background laid a strong foundation for his illustrious career in biotechnology and pharmaceuticals. He earned his Bachelor of Science degree in Chemistry from the University of Michigan, where he developed a keen interest in medicinal chemistry. Rosen then pursued a Ph.D. in Organic Chemistry at the University of California, Berkeley, one of the leading institutions in the field. His academic journey equipped him with the knowledge and skills that would later drive his success in drug discovery and development, ultimately leading to his leadership roles at prominent companies like Arcus Biosciences and Flexus Biosciences.
When did Terry Rosen join Arcus Biosciences?
In 2015, Terry Rosen co-founded Arcus Biosciences, a company dedicated to innovative cancer treatments. Since its inception, Rosen has served as the CEO, guiding the company with his extensive experience in drug discovery and development. As of 2024, he has been with Arcus Biosciences for approximately nine years, leading the charge in leveraging the immune system to combat cancer.